Harrow Health Inc Earnings

The next earnings date for Harrow Health Inc is November 17, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Harrow Health Inc Earnings

Report DateEstimated Earnings Per Share
11/17/2025$0.19

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Harrow Health Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/12/2025---$0-100.00%
05/12/2025After Market$-0.38-90.00%
03/17/2025Before Market------
11/13/2024After Market$-0.050.00%
08/07/2024After Market$-0.1810.00%
05/13/2024After Market$-0.38-90.00%
03/19/2024After Market$-0.25-525.00%
11/13/2023After Market$-0.13-425.00%
08/09/2023After Market$-0.14-250.00%
05/11/2023After Market$-0.22-340.00%
03/23/2023After Market$0.04133.33%
11/14/2022After Market$-0.24-1,704.51%
08/09/2022After Market$-0.23-2,200.00%
05/05/2022After Market$0.03175.00%
03/10/2022After Market$-0.27-575.00%
11/09/2021After Market$-0.31-1,450.00%
08/10/2021After Market$-0.09-200.00%
05/11/2021After Market$0.01125.00%
03/08/2021After Market$0.040.00%
11/09/2020After Market$0.040.00%
08/10/2020After Market$-0.0190.00%
05/11/2020After Market$-0.50-100.00%
03/13/2020Before Market$0.1066.67%
11/13/2019After Market$-0.29-20.83%
08/14/2019After Market$-0.09-12.50%
05/09/2019After Market$0.434,400.00%
03/12/2019After Market$0.77126.47%
11/13/2018After Market$-0.120.00%
08/06/2018After Market$0.11191.67%
05/15/2018After Market$-0.17-6.25%
03/08/2018After Market$-0.13---
11/14/2017After Market$-0.28---
08/10/2017After Market$-0.26---
05/10/2017After Market$-0.26-36.84%
03/21/2017After Market$-0.30-7.14%
11/14/2016After Market$-0.29---
08/15/2016After Market$-0.35---
05/12/2016After Market$-0.42-55.56%
03/23/2016After Market$-0.48-84.62%
11/12/2015After Market$-0.41-7.89%
08/12/2015After Market$-0.39-25.81%
05/13/2015After Market$-0.33-32.00%
03/12/2015After Market$-0.30-15.38%
11/12/2014---$-0.30-20.00%
09/03/2014---$-0.28---
05/28/2014---$-0.26---
02/26/2014---$-0.21---
11/11/2013---$-0.23---
08/28/2013---$-0.25---
05/29/2013---$-0.19---
02/27/2013---$-0.32---
11/28/2012---$-0.20---
08/29/2012---$-0.39---
05/30/2012---$-1.30---
02/29/2012---$-0.93---
11/30/2011---$-0.21---
08/31/2011---$-0.41---
06/01/2011---$-1.09---
03/02/2011---$-1.08---
11/08/2010---$-2-66.67%
08/12/2010---$-1.200.00%
06/02/2010---$-2.22---
03/03/2010---$-2---
12/02/2009---$-2.38---
09/02/2009---$-3.15---
06/03/2009---$-4.17---
02/25/2009---$-2.57---
12/03/2008---$-2.11---
09/03/2008---$-3.43---
05/28/2008---$-0.79---
02/27/2008---$-6.87---
09/30/2007---$-11.48---

More About Harrow Health Inc

Website
https://www.harrow.com
Country
USA
Full Time Employees
382

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; MAXIDEX and FLAREX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and the eye; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and NATACYN, a sterile, antifungal drug for the treatment of fungal blepharitis, conjunctivitis, and keratitis. In addition, it offers TOBRADEX ST, a tobramycin and dexamethasone ophthalmic suspension; VERKAZIA cyclosporine ophthalmic emulsion; NEVANAC, a non-steroidal, anti-inflammatory eye drop; and FRESHKOTE preservative free (PF) is a lubricant eye drop. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee.

“Harrow Health Inc Earnings” Can Refer to the Harrow Health Inc Earnings Date

Some people say “Harrow Health Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Harrow Health Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Harrow Health Inc Stock on the Earnings Date

If you own Harrow Health Inc stock (HROW) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Harrow Health Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Harrow Health Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Harrow Health Inc Earnings

You can contact us any time if you would like to ask questions about Harrow Health Inc earnings or anything else related to the stock market.